Mofebutazone

Mofebutazone
Clinical data
ATC code	M01AA02 (WHO) M02AA02 (WHO);
Identifiers
	IUPAC name 4-butyl-1-phenylpyrazolidine-3,5-dione;
CAS Number	2210-63-1 ;
PubChem CID	16639;
ChemSpider	15776 ;
UNII	SPW36WUI5Z;
KEGG	D07262 ;
ChEBI	CHEBI:76252 ;
CompTox Dashboard (EPA)	DTXSID4023331 ;
ECHA InfoCard	100.016.947
Chemical and physical data
Formula	C13H16N2O2
Molar mass	232.283 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCC1C(=O)NN(C1=O)c2ccccc2;
	InChI InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16) ; Key:REOJLIXKJWXUGB-UHFFFAOYSA-N ;
	(what is this?) (verify)

Mofebutazone (or monophenylbutazone) is a drug used for joint and muscular pain.^[1]^[2] It is a 3,5-pyrazolinedione derivative.

The drug binds to plasma albumin and competes with drugs such as coumarin anticoagulants, indomethacin and glucocorticoids.

References

Clinical data

ATC code	M01AA02 (WHO) M02AA02 (WHO)
Identifiers
IUPAC name 4-butyl-1-phenylpyrazolidine-3,5-dione
CAS Number	2210-63-1^Y
PubChem CID	16639
ChemSpider	15776^N
UNII	SPW36WUI5Z
KEGG	D07262^Y
ChEBI	CHEBI:76252^N
CompTox Dashboard (EPA)	DTXSID4023331
ECHA InfoCard	100.016.947
Chemical and physical data
Formula	C₁₃H₁₆N₂O₂
Molar mass	232.283 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CCCCC1C(=O)NN(C1=O)c2ccccc2
InChI InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16)^N Key:REOJLIXKJWXUGB-UHFFFAOYSA-N^N
^NY (what is this?) (verify)